Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like SYGNIS Reports Financial Results For The Second Quarter And First Six Months Of 2017 August 2, 2017 Reunited and It Feels So Good: After the Success of Serial Biotech Duo Launches February 8, 2017 7 PDUFA Dates to Mark on Your Calendars for September September 5, 2017